| Name | Title | Contact Details |
|---|
Medical Murray specializes in medical device development, testing and contract manufacturing services - with expertise in catheters, implants, and more.
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
Advanced Accelerator Applications is a pharmaceutical group specialized in the field of nuclear medicine.
Mylan Inc. (Mylan) and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients (API). As of
Stone and Magnanini is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.